Respiratory medicine
-
Respiratory medicine · Oct 2015
Randomized Controlled TrialTiotropium + olodaterol shows clinically meaningful improvements in quality of life.
Tiotropium + olodaterol improves lung function and symptoms compared to monotherapies in chronic obstructive pulmonary disease (COPD). The OTEMTO 1 and 2 studies investigated the effects of tiotropium + olodaterol on lung function and health-related quality of life compared to placebo in patients with moderate to severe COPD. ⋯ Tiotropium + olodaterol improved lung function and quality of life compared to placebo and tiotropium 5 μg.